IDT Australia | n Australian pharmaceutical contract manufacturing organisation (CMO) with 25 years experience in the development, scale up and commercial production of high potency active pharmaceutical ingredients (HPAPI) and finished dosage forms. IDT manufactures and formulates high potency compounds including antibiotics (Penems), cytotoxic anti-cancer agents and controlled substances in dedicated containment facilities under cGMP conditions. These facilities are audited by the US FDA and the TGA

Welcome to IDT Australia Limited

IDT is an Australian pharmaceutical contract manufacturing company with 25 years experience in the development and production of highly potent (HPAPI) pharmaceutical products for local and international clients.

IDT’s facilities are fully cGMP and are regularly audited by the US FDA and Australian TGA.

With an experienced and professional team, operating within world class facilities, IDT is committed to providing a full scale service in the areas of cGMP high-potency API manufacture, new drug development and scale-up, clinical research services and pharmacy services.

Located in Melbourne, Australia, IDT is able to provide a comprehensive range of services, which can be tailored to meet the specific requirements of each customer, whilst receiving regulatory approvals in the shortest time possible due to a rigorous in-house controls process.

Competitive drug development and manufacture located in the fast-growing Asia Pacific region

IDT commercially manufactures API’s to international quality standards, with an emphasis on anti-cancer drugs